DIANE SMITH: Open Payments
NPI 1316139413 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,850 in 131 payments from 21 companies in 2025. Trend: 2023 $4,658 · 2024 $3,850 · 2025 $3,850
Food & beverage: $3,585Education: $265
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $870 |
| Janssen Biotech, Inc. | 22 | $462 |
| Regeneron Healthcare Solutions, Inc. | 11 | $418 |
| GENZYME CORPORATION | 4 | $261 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $238 |
| Lilly USA, LLC | 5 | $236 |
| Amgen Inc. | 7 | $233 |
| UCB, Inc. | 7 | $226 |
| LEO Pharma Inc. | 5 | $192 |
| Incyte Corporation | 5 | $182 |
Products named: DUPIXENT, BOTOX, TREMFYA, Otezla, Bimzelx, EBGLYSS, OPZELURA, RINVOQ.
Industry payments across NV — which companies pay providers there.
